Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
BB Biotech AG is an investment company that focuses on investments in the biotechnology industry. The company is headquartered in Schaffhausen, Switzerland, and specializes in managing a portfolio primarily composed of companies involved in the development of innovative drugs and therapies. It seeks to capture growth opportunities in the biotech sector by investing in firms with cutting-edge scientific research and promising product pipelines. BB Biotech AG's investment strategy is informed by an in-depth analysis of market trends and scientific advancements, ensuring a dynamic and diversified portfolio. Its geographic footprint is primarily in Europe, with strategic investments in biotech firms globally.
View stock
VS
JPMorgan Chase is a leading global financial-services firm with operations in 66 countries and nearly 323,000 employees as of September 2026. Under the JPMorgan brands, the bank holding company boasts a $5.1 trillion balance sheet and $2.78 trillion in deposits as of September 2026. The firm generates its revenue across three core operating segments: consumer and community banking, the commercial and investment bank, and asset and wealth management. It maintains the top global ranking in investment banking fees with an 8.4% market share, serves millions of consumers through its network of over 5,000 US branches, and manages nearly $7.9 trillion in client assets within its wealth and asset management franchise.
View stock

Stock highlights

Stock comparison highlights
Stock name
BB Biotech AGJPMorgan Chase
Last price
€58.80$342.82
Currency
EUR
USD
€3.3B$912B
2.7814.42
€21.15$23.81
0.671.02
€2.46$6.15
4.18%1.92%
Sector
FinanceFinance
Employees
10322,964
Ticker
€BION$JPM
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €BION or $JPM on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.